Lignocaine is one of 88 small molecule programs targeting Cataract. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
63 competitors in Cataract
Eylea
Avelox
Decadron
Bromday
Precedex
Lovenox
Toradol
Voltaren
Cipro
Deltasone
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details